Cold Chain Requirements for Oncology Drugs
Many chemotherapy agents particularly monoclonal antibodies, targeted therapies and biologic cancer treatments require strict temperature control throughout the supply chain. A temperature excursion during transit can compromise product integrity, create patient safety risks and trigger regulatory incident reporting. For hospital pharmacy departments, oncology units and specialist pharmaceutical wholesalers, the cold chain or TempChain packaging they choose is a critical element of safe, compliant drug distribution.
​
Cytotoxic drugs in particular present challenges: they must be maintained within a precise temperature range while also being handled safely to protect staff and patients. Hospital pharmacists and procurement leads need packaging that is proven, documented and sourced from a trusted supplier who understands the NHS supply chain environment.
​
Puffin Packaging’s Lunda TempChain range provides qualified TempChain packaging for oncology applications, backed by responsive specialist support and the documentation that pharmacy, procurement and QA teams need to make confident decisions.
​
​
Lunda TempChain for Oncology & Chemotherapy Applications
Typical Applications: mAbs, cytotoxics, targeted therapies, NHS Supply, direct and via wholesalers.
​
​
Why hospital pharmacy teams and oncology units choose Lunda TempChain:
🗹 Several Temperature Profiles Qualified
To maintain temperature for monoclonal antibodies, cytotoxics and other cold-chain oncology drugs
​
🗹 GDP-Compliant
Meets requirements for TempChain pharmaceutical distribution in hospital settings
​
🗹 NHS-Ready Supply Model
We understand NHS procurement frameworks and can supply direct or via authorised wholesalers
​
🗹 Qualification Documentation Available
Supporting hospital QA departments and commissioner audit requirements
​
🗹 ISO 9001 & 14001
Certified quality and environmental management standards
​
🗹 Experts
Faster delivery, responsive support and no import logistics complexity
​
​
Frequently Asked Questions
Is your packaging suitable for cytotoxic drug transport?
Yes. Lunda TempChain packaging maintains drugs at 2°C to 8°C or frozen or ultra-cold temperatures, which covers the storage and distribution requirements for the majority of cytotoxic oncology treatments including monoclonal antibodies and targeted therapies.
Please note that Lunda TempChain products are not a standalone cytotoxic containment system and provides temperature control only; Please ensure your primary containment and spillage procedures comply with your local oncology pharmacy protocols.
​
Can you supply to NHS hospital trusts directly?
Yes. We supply cold chain packaging to NHS hospital trusts, hospital pharmacy departments, oncology units and via NHS-approved pharmaceutical wholesalers. We can accommodate NHS procurement frameworks and provide the documentation and certification required for NHS approved supplier processes. Contact our team to discuss your trust's specific requirements.
​
Do you provide qualification data to support hospital QA requirements?
Yes. We provide qualification performance data for Lunda TempChain solutions. These documents support hospital pharmacy QA audits.
​
What is the minimum order quantity for hospital pharmacy departments?
We do not impose minimum order quantities that are prohibitive for individual hospital pharmacy departments. We understand that oncology cold chain needs vary significantly by trust size and product mix. We also provide free samples so your pharmacy team can evaluate the packaging before committing to a stock order.
​
Does your packaging align with NHS net-zero targets?
Yes. Puffin Packaging is ISO 14001 certified and select Lunda TempChain range is designed with sustainability in mind using reusable, recyclable, sustainable materials.